NEW
YORK, Feb. 23, 2023 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and its board of
directors concerning the proposed acquisition of the company by MEI
Pharma, Inc. (NASDAQ: MEIP). Infinity Pharmaceutical stockholders
are expected to own 42% of the combined company. The all-stock
transaction is expected to close in mid-2023.
If you are a stockholder of Infinity Pharmaceuticals, Inc. and
are interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/infi/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-infinity-pharmaceuticals-inc-301754822.html
SOURCE Rowley Law PLLC